NCT03513809

Brief Summary

Spontaneous breathing efforts in patients with respiratory failure connected to mechanical ventilation, has been associated with strong respiratory muscles activity. However, these mechanisms may will be present in patients with acute lung deseases who are breathing with no ventilatory support. We hypothesize that spontaneous breathing during acute respiratory failure could induced lung inflammation and worsen lung damage. Hereby, the connection to a ventilatory support tool, may protect the lungs from spontaneous ventilation-induced lung injury. To test our hypothesis, our aim is to determine the effects of spontaneous breathing in acute respiratory failure patients, on lung injury distribution; and to determine whether early controlled mechanical ventilation can avoid these deleterious effects by improving air distribution.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 2, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2021

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

3.8 years

First QC Date

April 19, 2018

Last Update Submit

March 8, 2021

Conditions

Keywords

Acute Hypoxemic Respiratory FailureAcute Respiratory Distress SyndromeElectrical impedance tomographySpontaneous breathingVentilation induced-lung injuryPatient self-inflicted lung injury

Outcome Measures

Primary Outcomes (1)

  • Inflammation

    Cytokine analysis (TNF-α, IL-1β, IL-6, IL-8 and IL-10) in serum, bronchoalveolar lavage fluid (BALF) and tissue supernatants.

    Plasma: At the time of enrollment and 48 hours post intubation. BALF: Immediately post intubation and 48-96 hours post intubation (only if it is required and indicated by the attending physician).

Secondary Outcomes (1)

  • Pulmonary ventilation distribution

    Every 6 hours from enrollment to intubation and after connection to mechanical ventilation each hour for the first 6 hours and then at 12, 18, 24 and 48 hours.

Study Arms (1)

Acute hypoxemic respiratory failure

Patients with acute hypoxemic respiratory failure breathing spontaneously with no requirements of immediate intubation connected to thoracic electrical impedance tomography.

Device: Thoracic electrical impedance tomography

Interventions

Non invasive, radiation-free, bedside monitoring tool for distribution of pulmonary ventilation.

Acute hypoxemic respiratory failure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the ICU of the Hospital Clínico UC-Christus, Santiago de Chile, with diagnosis of acute hypoxemic respiratory failure, but who are still ventilating spontaneously.

You may qualify if:

  • Acute respiratory symptoms for less than seven days
  • Acute hypoxemic respiratory failure defined by a ratio of partial pressure of arterial oxygen (Pao2) to Fio2 of 300 mm Hg or less, while breathing with standard oxygen mask at FiO2 \> or equal to 30%
  • Increased work of breathing defined by either:
  • i. Respiratory rate \> 25 / min, or ii. Signs of intercostal or supraclavicular retraction
  • Less than 24 hours since criteria 2 and 3 are met.

You may not qualify if:

  • Acute respiratory failure secondary to exacerbation of chronic respiratory disease or to cardiogenic pulmonary edema, PaCO2 \> 45 mm Hg, decreased conscious level (Glasgow Coma Scale \< 13), urgent need for endotracheal intubation, a decision not to resuscitate, and consent refusal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universidad Católica

Santiago, Chile

RECRUITING

Related Publications (4)

  • Brochard L. Ventilation-induced lung injury exists in spontaneously breathing patients with acute respiratory failure: Yes. Intensive Care Med. 2017 Feb;43(2):250-252. doi: 10.1007/s00134-016-4645-4. Epub 2017 Jan 10. No abstract available.

  • Mascheroni D, Kolobow T, Fumagalli R, Moretti MP, Chen V, Buckhold D. Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study. Intensive Care Med. 1988;15(1):8-14. doi: 10.1007/BF00255628.

  • Yoshida T, Uchiyama A, Fujino Y. The role of spontaneous effort during mechanical ventilation: normal lung versus injured lung. J Intensive Care. 2015 Jun 17;3:18. doi: 10.1186/s40560-015-0083-6. eCollection 2015.

  • Yoshida T, Fujino Y, Amato MB, Kavanagh BP. Fifty Years of Research in ARDS. Spontaneous Breathing during Mechanical Ventilation. Risks, Mechanisms, and Management. Am J Respir Crit Care Med. 2017 Apr 15;195(8):985-992. doi: 10.1164/rccm.201604-0748CP.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma samples and bronchoalveolar lavage samples.

MeSH Terms

Conditions

Respiratory InsufficiencyRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesLung Diseases

Study Officials

  • Jaime A Retamal

    Pontificia Universidad Catolica de Chile

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jaime A Retamal

CONTACT

María C Bachmann

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 19, 2018

First Posted

May 2, 2018

Study Start

June 8, 2017

Primary Completion

March 21, 2021

Study Completion

March 31, 2021

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

There isn't plan for IPD

Locations